000 01468 a2200421 4500
005 20250518070030.0
264 0 _c20201013
008 202010s 0 0 eng d
022 _a2284-0729
024 7 _a10.26355/eurrev_201910_19311
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShi, C-K
245 0 0 _aTherapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway.
_h[electronic resource]
260 _bEuropean review for medical and pharmacological sciences
_cOct 2019
300 _a9085-9092 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aFibroblasts
_xcytology
650 0 4 _aHumans
650 0 4 _aInterleukin-10
_xpharmacology
650 0 4 _aKeloid
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrimary Cell Culture
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSmad Proteins
_xmetabolism
650 0 4 _aTime Factors
650 0 4 _aTransforming Growth Factor beta
_xmetabolism
650 0 4 _aYoung Adult
700 1 _aZhao, Y-P
700 1 _aGe, P
700 1 _aHuang, G-B
773 0 _tEuropean review for medical and pharmacological sciences
_gvol. 23
_gno. 20
_gp. 9085-9092
856 4 0 _uhttps://doi.org/10.26355/eurrev_201910_19311
_zAvailable from publisher's website
999 _c30282940
_d30282940